Matthew Yglesias @mattyglesias
@JInterlandi This all sounds pretty restrictive. Now perhaps the FDA is right and the EMA is being too lax. But the US/EU gap in test availability seems to me to be largely driven by the EMA approving more vendors. https://t.co/cC4E2v4FHf https://t.co/t79sUJ49wO — PolitiTweet.org